Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of voclosporin in active non-infectious intermediate/posterior uveitis
2010-022128-63Phase 3Completed
- Sponsor
- Lux Biosciences, Inc.
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in noninfectious uveitis (NIU), Hyalitis, posterior uveitis and 1 more comparing Voclosporin with Placebo (2 arms). Primary endpoint: Change from baseline in graded vitreous haze. Started Nov 2010; status: completed.
02
Drugs
voclosporin
03
Conditions
noninfectious uveitis (NIU)Hyalitisposterior uveitispanuveitis
Beyond the preview
Go deeper on 2010-022128-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022128-63.